BriaCell Therapeutics Corp. (BCTX) stock
BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
$3.28−0.23 (-6.55%)
Close on Nov 18, 2026Market cap $28.64MP/E –Yield –
BriaCell Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
BriaCell Therapeutics's free cash flow for the twelve months ending Jul 31, 2026 was -$28.78M. For fiscal 2026 it was -$28.78M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | -$28.78M | – |
| FY2024 | Jul 31, 2024 | -$24.58M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | -$5.96M | – |
See a number that looks wrong?